(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Methes Energies International Ltd, Northwest Biotherapeutics, and BlackBerry.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Methes Energies International Ltd (MEIL) | 0.02 | 30.16% | 2023-08-24 19:08:07 |
| 2 | Northwest Biotherapeutics (NWBO) | 0.53 | 26.22% | 2023-08-25 03:47:07 |
| 3 | BlackBerry (BB) | 5.18 | 16.86% | 2023-08-25 13:20:56 |
| 4 | OSI Systems (OSIS) | 136.69 | 13.75% | 2023-08-25 07:47:08 |
| 5 | Ebix (EBIX) | 15.37 | 9.01% | 2023-08-25 13:19:15 |
| 6 | Advanced Semiconductor Engineering (ASX) | 8.14 | 8.18% | 2023-08-25 13:11:13 |
| 7 | Fastly (FSLY) | 21.99 | 8.09% | 2023-08-25 13:20:47 |
| 8 | Nikola (NKLA) | 1.32 | 7.76% | 2023-08-25 13:02:01 |
| 9 | Groupon (GRPN) | 13.04 | 7.06% | 2023-08-25 13:20:23 |
| 10 | Gap (GPS) | 10.17 | 6.72% | 2023-08-25 13:14:44 |
The three biggest losers today are Neptune Wellness Solutions, AMC, and Weibo.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Neptune Wellness Solutions (NEPT) | 0.20 | -13.06% | 2023-08-25 01:09:07 |
| 2 | AMC (AMC) | 12.58 | -12.43% | 2023-08-25 13:27:35 |
| 3 | Weibo (WB) | 12.48 | -8.91% | 2023-08-25 13:23:32 |
| 4 | Omeros Corporation (OMER) | 3.52 | -7.85% | 2023-08-25 07:10:08 |
| 5 | Motorcar Parts of America (MPAA) | 8.15 | -7.18% | 2023-08-24 22:23:07 |
| 6 | NeuroMetrix (NURO) | 0.67 | -6.55% | 2023-08-25 13:09:09 |
| 7 | Oncolytics Biotech (ONCY) | 2.30 | -6.5% | 2023-08-25 07:13:10 |
| 8 | PRA Group (PRAA) | 18.28 | -6.3% | 2023-08-25 15:46:08 |
| 9 | Mirati Therapeutics (MRTX) | 35.19 | -6.28% | 2023-08-24 23:07:08 |
| 10 | Marvell Technology Group (MRVL) | 53.71 | -6.25% | 2023-08-25 13:21:27 |
Winners today
1. Methes Energies International Ltd (MEIL) – 30.16%
Methes Energies International Ltd., a renewable energy company, produces and sells biodiesel fuel and biodiesel processing equipment in the United States and Canada. It offers Denami biodiesel processors. The company also produces glycerin and offer services related to the production of biodiesel, as well as purchases and sells feedstock. It sells its products and services to a network of biodiesel fuel producers. The company was founded in 2004 and is headquartered in Las Vegas, Nevada.
NASDAQ ended the session with Methes Energies International Ltd rising 30.16% to $0.02 on Friday, following the last session’s upward trend. NASDAQ jumped 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Methes Energies International Ltd has a trailing twelve months EPS of $-0.24.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.54%.
More news about Methes Energies International Ltd.
2. Northwest Biotherapeutics (NWBO) – 26.22%
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
NASDAQ ended the session with Northwest Biotherapeutics jumping 26.22% to $0.53 on Friday, following the last session’s upward trend. NASDAQ rose 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, Northwest Biotherapeutics has a trailing twelve months EPS of $-0.07.
Yearly Top and Bottom Value
Northwest Biotherapeutics’s stock is valued at $0.53 at 17:32 EST, way below its 52-week high of $1.27 and way higher than its 52-week low of $0.40.
Revenue Growth
Year-on-year quarterly revenue growth declined by 57.9%, now sitting on 1.88M for the twelve trailing months.
Moving Average
Northwest Biotherapeutics’s worth is under its 50-day moving average of $0.54 and way under its 200-day moving average of $0.66.
Volume
Today’s last reported volume for Northwest Biotherapeutics is 2846530 which is 86.77% above its average volume of 1524070.
More news about Northwest Biotherapeutics.
3. BlackBerry (BB) – 16.86%
NYSE ended the session with BlackBerry rising 16.86% to $5.18 on Friday, after two sequential sessions in a row of losses. NYSE jumped 0.54% to $15,766.91, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BlackBerry’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 20% and 80%, respectively.
More news about BlackBerry.
4. OSI Systems (OSIS) – 13.75%
OSI Systems, Inc. designs, manufactures, and sells electronic systems and components worldwide. It operates through three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, radiation detection, hold baggage and people screening, and explosive and narcotics trace detection systems under the Rapiscan Systems and AS&E names. It also provides site design, installation, training, and technical support services; and security screening solutions under the S2 name. The Healthcare segment offers patient monitoring and diagnostic cardiology systems, and related supplies and accessories under the Spacelabs name for use in critical care, emergency, and perioperative areas within hospitals, physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment provides optoelectronic devices under the OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix names for the aerospace and defense, avionics, medical imaging and diagnostics, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets. It also offers electronics manufacturing services to original equipment manufacturers and end users for medical, automotive, defense, aerospace, industrial, and consumer applications under the OSI Electronics, APlus Products, Altaflex, and PFC names; and LCD displays for medical, industrial, and consumer electronics applications, as well as flex circuits for OEM customers. This segment offers laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan and Autosense names; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode name. The company was incorporated in 1987 and is headquartered in Hawthorne, California.
NASDAQ ended the session with OSI Systems jumping 13.75% to $136.69 on Friday while NASDAQ jumped 0.94% to $13,590.65.
Earnings Per Share
As for profitability, OSI Systems has a trailing twelve months EPS of $4.85.
PE Ratio
OSI Systems has a trailing twelve months price to earnings ratio of 28.18. Meaning, the purchaser of the share is investing $28.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.94%.
Moving Average
OSI Systems’s value is way above its 50-day moving average of $119.15 and way above its 200-day moving average of $102.99.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 3.4% and 47.1%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
OSI Systems’s EBITDA is 59.69.
More news about OSI Systems.
5. Ebix (EBIX) – 9.01%
Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.
NASDAQ ended the session with Ebix jumping 9.01% to $15.37 on Friday while NASDAQ rose 0.94% to $13,590.65.
Earnings Per Share
As for profitability, Ebix has a trailing twelve months EPS of $1.09.
PE Ratio
Ebix has a trailing twelve months price to earnings ratio of 14.1. Meaning, the purchaser of the share is investing $14.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.
More news about Ebix.
6. Advanced Semiconductor Engineering (ASX) – 8.18%
ASE Technology Holding Co., Ltd., together with its subsidiaries, provides semiconductors packaging and testing, and electronic manufacturing services in the United States, Taiwan, Asia, Europe, and internationally. It develops, constructs, sells, leases, and manages real estate properties; produces substrates; offers information software, equipment leasing, investment advisory, and warehousing management services; processes and sells computer and communication peripherals, electronic components, telecommunications equipment, and motherboards; and imports and exports goods and technology. ASE Technology Holding Co., Ltd. was founded in 1984 and is headquartered in Kaohsiung, Taiwan.
NYSE ended the session with Advanced Semiconductor Engineering jumping 8.18% to $8.14 on Friday, following the last session’s downward trend. NYSE jumped 0.54% to $15,766.91, following the last session’s downward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, Advanced Semiconductor Engineering has a trailing twelve months EPS of $0.65.
PE Ratio
Advanced Semiconductor Engineering has a trailing twelve months price to earnings ratio of 12.52. Meaning, the purchaser of the share is investing $12.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.98%.
Sales Growth
Advanced Semiconductor Engineering’s sales growth is negative 14% for the current quarter and 0.5% for the next.
Moving Average
Advanced Semiconductor Engineering’s worth is above its 50-day moving average of $8.06 and way higher than its 200-day moving average of $7.28.
More news about Advanced Semiconductor Engineering.
7. Fastly (FSLY) – 8.09%
Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; network services to speed up and optimize the delivery of web and application traffic; device detection and geolocation; content delivery network, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, programmatic control, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming and media shield. It also provides edge security solutions, such as DDoS protection, next-gen WAF, bot protection, API and ATO protection, advanced rate limiting, and compliance services; transport layer security (TLS) and platform TLS; and origin connect. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail and education, SaaS, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.
NYSE ended the session with Fastly rising 8.09% to $21.99 on Friday while NYSE jumped 0.54% to $15,766.91.
Earnings Per Share
As for profitability, Fastly has a trailing twelve months EPS of $-1.47.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 50% and 50%, respectively.
More news about Fastly.
8. Nikola (NKLA) – 7.76%
Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions. It operates through two business units, Truck and Energy. The Truck business unit develops and commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. The Energy business unit develops and constructs a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. The company also assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.
NASDAQ ended the session with Nikola jumping 7.76% to $1.32 on Friday, after four sequential sessions in a row of losses. NASDAQ rose 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Nikola has a trailing twelve months EPS of $-1.27.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -132.55%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 39.3% and 62.2%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth declined by 15.3%, now sitting on 56.84M for the twelve trailing months.
Moving Average
Nikola’s value is way under its 50-day moving average of $1.81 and way under its 200-day moving average of $1.87.
Volatility
Nikola’s last week, last month’s, and last quarter’s current intraday variation average was a negative 12.87%, a negative 2.62%, and a positive 9.47%.
Nikola’s highest amplitude of average volatility was 12.87% (last week), 9.73% (last month), and 9.47% (last quarter).
More news about Nikola.
9. Groupon (GRPN) – 7.06%
Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.
NASDAQ ended the session with Groupon rising 7.06% to $13.04 on Friday, after three consecutive sessions in a row of gains. NASDAQ jumped 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Groupon has a trailing twelve months EPS of $-5.65.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -309.27%.
Sales Growth
Groupon’s sales growth is negative 12.1% for the present quarter and negative 6.1% for the next.
Volume
Today’s last reported volume for Groupon is 1567890 which is 11.62% above its average volume of 1404550.
Volatility
Groupon’s last week, last month’s, and last quarter’s current intraday variation average was 1.99%, 2.81%, and 5.52%.
Groupon’s highest amplitude of average volatility was 5.91% (last week), 5.77% (last month), and 5.52% (last quarter).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Groupon’s EBITDA is 0.97.
More news about Groupon.
10. Gap (GPS) – 6.72%
The Gap, Inc. operates as an apparel retail company. The company offers apparel, accessories, and personal care products for men, women, and children under the Old Navy, Gap, Banana Republic, and Athleta brands. Its products include denim and khakis; eyewear, jewelry, shoes, handbags, and fragrances; and fitness and lifestyle products for use in yoga, training, sports, travel, and everyday activities for women and girls. The company offers its products through company-operated stores, franchise stores, websites, and third-party arrangements. It has franchise agreements to operate Old Navy, Gap, Banana Republic, and Athleta stores and websites in Asia, Europe, Latin America, the Middle East, and Africa. The company also provides its products through e-commerce sites. The Gap, Inc. was incorporated in 1969 and is headquartered in San Francisco, California.
NYSE ended the session with Gap rising 6.72% to $10.17 on Friday, following the last session’s downward trend. NYSE jumped 0.54% to $15,766.91, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Gap has a trailing twelve months EPS of $-0.16.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.5%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 25% and a drop 53.5% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Gap’s stock is considered to be overbought (>=80).
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.8%, now sitting on 15.42B for the twelve trailing months.
Previous days news about Gap
- Gap (gps) tops Q2 earnings estimates. According to Zacks on Thursday, 24 August, "While Gap has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"
- Here's what key metrics tell us about gap (gps) Q2 earnings. According to Zacks on Thursday, 24 August, "For the quarter ended July 2023, Gap (GPS Quick QuoteGPS – Free Report) reported revenue of $3.55 billion, down 8% over the same period last year. ", "Here is how Gap performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Gap.
Losers Today
1. Neptune Wellness Solutions (NEPT) – -13.06%
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga Neutraceuticals, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, and NurturMe brands. The company offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, such as legal cannabis and hemp, nutraceuticals, and white label consumer packaged goods. It is also involved in the extraction, purification, formulation, and manufacturing of health and wellness products, such as omega-3 and hemp-derived products under various delivery forms, such as soft gels, liquids, capsules, vape pens, sprays, topicals, sachets, tinctures, concentrates, edibles, and beverages, as well as hand sanitizers, non-contact thermometers, and gloves. In addition, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
NASDAQ ended the session with Neptune Wellness Solutions sliding 13.06% to $0.20 on Friday, following the last session’s downward trend. NASDAQ jumped 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Neptune Wellness Solutions has a trailing twelve months EPS of $-4.22.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -818.48%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Neptune Wellness Solutions’s EBITDA is 0.66.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 67.6% and 19%, respectively.
Yearly Top and Bottom Value
Neptune Wellness Solutions’s stock is valued at $0.20 at 17:32 EST, way under its 52-week high of $2.93 and way above its 52-week low of $0.11.
Moving Average
Neptune Wellness Solutions’s worth is way higher than its 50-day moving average of $0.15 and way under its 200-day moving average of $0.45.
More news about Neptune Wellness Solutions.
2. AMC (AMC) – -12.43%
AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. AMC Entertainment Holdings, Inc. was founded in 1920 and is headquartered in Leawood, Kansas.
NYSE ended the session with AMC sliding 12.43% to $12.58 on Friday, after four consecutive sessions in a row of losses. NYSE rose 0.54% to $15,766.91, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, AMC has a trailing twelve months EPS of $-5.
More news about AMC.
3. Weibo (WB) – -8.91%
Weibo Corporation, through its subsidiaries, operates as a social media platform for people to create, distribute, and discover content in the People's Republic of China. It operates in two segments, Advertising and Marketing Services; and Value-Added Services. The company offers discovery products to help users discover content on its platform; self-expression products that enable its users to express themselves on its platform; and social products to promote social interaction between users on its platform. It also provides advertising and marketing solutions, such as social display advertisements; and promoted marketing offerings, such as Fans Headline and Weibo Express promoted feeds, as well as promoted trends and search products that appear alongside user's trends discovery and search behaviors. In addition, the company offers products, such as trends, search, video/live streaming, and editing tools; content customization, copyright contents pooling, and user interaction development; and search list recommendation, trends list recommendation, and Weibo app opening advertisements. Further, it provides back-end management, traffic support, and product solutions to MCNs, unions, and e-commerce partners; open application platform for other app developers that allows users to log into third-party applications with their Weibo account for sharing third-party content on its platform; and Weibo Wallet, a product that enables platform partners to conduct interest generation activities on Weibo, such as handing out red envelops and coupons. The company was formerly known as T.CN Corporation and changed its name to Weibo Corporation in 2012. The company was founded in 2009 and is headquartered in Beijing, China. Weibo Corporation operates as a subsidiary of Sina Corporation.
NASDAQ ended the session with Weibo dropping 8.91% to $12.48 on Friday while NASDAQ jumped 0.94% to $13,590.65.
Earnings Per Share
As for profitability, Weibo has a trailing twelve months EPS of $1.1.
PE Ratio
Weibo has a trailing twelve months price to earnings ratio of 11.35. Meaning, the purchaser of the share is investing $11.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.7%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Weibo’s EBITDA is 45.97.
Volume
Today’s last reported volume for Weibo is 1578830 which is 30.56% above its average volume of 1209190.
More news about Weibo.
4. Omeros Corporation (OMER) – -7.85%
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN) and atypical hemolytic uremic syndrome (aHUS); and Phase II clinical trial to treat COVID-19. Its clinical programs also consist of PPAR? (OMS405) that is in Phase II to treat opioid and nicotine addiction; PDE7 (OMS527), which is in Phase I trial for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) that is in Phase I trial for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs also include GPR174 Inhibitors and Chimeric Antigen Receptor (CAR) T-Cell and Adoptive T-Cell Therapies for various cancers; and G protein-coupled receptor targets for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Omeros Corporation dropping 7.85% to $3.52 on Friday, following the last session’s downward trend. NASDAQ rose 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Omeros Corporation has a trailing twelve months EPS of $-2.71.
Yearly Top and Bottom Value
Omeros Corporation’s stock is valued at $3.52 at 17:32 EST, way below its 52-week high of $7.80 and way above its 52-week low of $1.74.
Moving Average
Omeros Corporation’s value is way under its 50-day moving average of $4.81 and way under its 200-day moving average of $4.23.
More news about Omeros Corporation.
5. Motorcar Parts of America (MPAA) – -7.18%
Motorcar Parts of America, Inc. manufactures, remanufactures, and distributes heavy-duty truck, industrial, marine, and agricultural application replacement parts. The company offers rotating electrical products, including alternators and starters; wheel hub assemblies and bearings; and brake-related products comprising brake calipers, brake boosters, brake rotors, brake pads, and brake master cylinders. It also offers test solutions and diagnostic equipment for electric vehicle powertrain development and manufacturing, including electric motor test systems, e-axle test systems, advanced power emulators, and charging unit test systems, as well as test systems for alternators, starters, belt starter generator, and bench-top testers used in the automotive retail segment and turbochargers. The company sells its products to automotive retail chain stores and warehouse distributors, as well as various automobile manufacturers for their aftermarket programs and warranty replacement programs in North America. Motorcar Parts of America, Inc. was founded in 1968 and is headquartered in Torrance, California.
NASDAQ ended the session with Motorcar Parts of America falling 7.18% to $8.15 on Friday, following the last session’s downward trend. NASDAQ rose 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, Motorcar Parts of America has a trailing twelve months EPS of $-0.26.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.7%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.6%, now sitting on 678.79M for the twelve trailing months.
More news about Motorcar Parts of America.
6. NeuroMetrix (NURO) – -6.55%
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix sliding 6.55% to $0.67 on Friday, following the last session’s downward trend. NASDAQ rose 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.76.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.14%.
Yearly Top and Bottom Value
NeuroMetrix’s stock is valued at $0.67 at 17:32 EST, way below its 52-week low of $0.77.
More news about NeuroMetrix.
7. Oncolytics Biotech (ONCY) – -6.5%
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
NASDAQ ended the session with Oncolytics Biotech dropping 6.5% to $2.30 on Friday while NASDAQ rose 0.94% to $13,590.65.
Earnings Per Share
As for profitability, Oncolytics Biotech has a trailing twelve months EPS of $-0.34.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -101.26%.
Moving Average
Oncolytics Biotech’s worth is below its 50-day moving average of $2.53 and way above its 200-day moving average of $1.82.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 33.3% and positive 27.3% for the next.
Yearly Top and Bottom Value
Oncolytics Biotech’s stock is valued at $2.30 at 17:32 EST, way below its 52-week high of $3.39 and way above its 52-week low of $1.09.
Volume
Today’s last reported volume for Oncolytics Biotech is 800306 which is 30.69% below its average volume of 1154730.
More news about Oncolytics Biotech.
8. PRA Group (PRAA) – -6.3%
PRA Group, Inc., a financial and business services company, engages in the purchase, collection, and management of portfolios of nonperforming loans in the Americas, Australia, and Europe. It is involved in the purchase of accounts that are primarily the unpaid obligations of individuals owed to credit originators, which include banks and other types of consumer, retail, and auto finance companies. The company also acquires nonperforming loans, including Visa and MasterCard credit cards, private label and other credit cards, installment loans, lines of credit, deficiency balances of various types, legal judgments, and trade payables from banks, credit unions, consumer finance companies, retailers, utilities, automobile finance companies, and other credit originators. In addition, it provides fee-based services on class action claims recoveries and by servicing consumer bankruptcy accounts. The company was formerly known as Portfolio Recovery Associates, Inc. and changed its name to PRA Group, Inc. in October 2014. PRA Group, Inc. was incorporated in 1996 and is headquartered in Norfolk, Virginia.
NASDAQ ended the session with PRA Group dropping 6.3% to $18.28 on Friday, following the last session’s downward trend. NASDAQ jumped 0.94% to $13,590.65, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, PRA Group has a trailing twelve months EPS of $-0.54.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.69%.
Sales Growth
PRA Group’s sales growth is negative 8.9% for the current quarter and negative 5.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 154% and a negative 168.3%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth declined by 19%, now sitting on 832.36M for the twelve trailing months.
Yearly Top and Bottom Value
PRA Group’s stock is valued at $18.28 at 17:32 EST, way under its 52-week high of $43.34 and higher than its 52-week low of $17.74.
More news about PRA Group.
9. Mirati Therapeutics (MRTX) – -6.28%
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase I/II clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase II clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib; and a clinical collaboration agreement with Novartis Pharmaceuticals Corporation. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.
NASDAQ ended the session with Mirati Therapeutics sliding 6.28% to $35.19 on Friday while NASDAQ jumped 0.94% to $13,590.65.
Earnings Per Share
As for profitability, Mirati Therapeutics has a trailing twelve months EPS of $-12.73.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -80.12%.
Sales Growth
Mirati Therapeutics’s sales growth is 1409.5% for the current quarter and 2584.2% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 155.3%, now sitting on 27.22M for the twelve trailing months.
More news about Mirati Therapeutics.
10. Marvell Technology Group (MRVL) – -6.25%
Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions, spanning the data center core to network edge. The company develops, scales complex System-on-a-Chip architectures, integrating analog, mixed-signal, and digital signal processing functionality. It offers a portfolio of Ethernet solutions, including controllers, network adapters, physical transceivers, and switches; single or multiple core processors; custom application specific integrated circuits; and System-on-a-Chip solutions. The company also provides electro-optical products, including pulse amplitude modulations, coherent digital signal processors, laser drivers, trans-impedance amplifiers, silicon photonics, and data center interconnect solutions; fibre channel products comprising host bus adapters and controllers; single or multiple core processors; storage controllers for hard disk drives and solid-state-drives; and host system interfaces, including serial attached SCSI, serial advanced technology attachment, peripheral component interconnect express, non-volatile memory express (NVMe), and NVMe over fabrics. It has operations in the United States, Argentina, China, India, Israel, Japan, Singapore, South Korea, Taiwan, and Vietnam. Marvell Technology, Inc. was incorporated in 1995 and is headquartered in Wilmington, Delaware.
NASDAQ ended the session with Marvell Technology Group falling 6.25% to $53.71 on Friday while NASDAQ jumped 0.94% to $13,590.65.
Earnings Per Share
As for profitability, Marvell Technology Group has a trailing twelve months EPS of $-0.19.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.08%.
Volume
Today’s last reported volume for Marvell Technology Group is 23943000 which is 66.01% above its average volume of 14422000.
More news about Marvell Technology Group.
Stay up to date with our winners and losers daily report
